Prenatal Counseling in Extreme Prematurity: Parents' View

NCT02782637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2016-05-25

No results posted yet for this study

Summary

This study is part of the PreCo study, evaluating Dutch care in (imminent) extreme preterm birth including current and preferred counseling, barriers and facilitators for preferred counseling from both obstetricians and neonatologists, as well as parents' views on this.

Since 2010, intensive care can be offered in the Netherlands at 24+0 weeks gestation (with parental consent) but as some international guidelines, the Dutch guideline lacks detailed recommendations on organization, content and preferred decision-making of the counselling.

Conditions

  • Extreme Prematurity
  • Complications

Interventions

OTHER

survey and interview

all participants: survey on prenatal counseling and treatment decisions at the limits of viability. a selection of participants: individual interviews to further perform in-depth exploration of prenatal counseling preferences

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Leiden University Medical Center

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Maastricht universitair medisch centrum, Maastricht

    collaborator UNKNOWN
  • Isala

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • Maxima Medical Center

    collaborator OTHER
  • Amsterdam UMC, location VUmc

    collaborator OTHER
  • Fonds NutsOhra

    collaborator OTHER
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Marije Hogeveen, MD, PhD · Radboud

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-03-31
Completion
2016-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782637 on ClinicalTrials.gov